Your browser doesn't support javascript.
loading
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
van Roozendaal, L M; de Wilt, J H W; van Dalen, T; van der Hage, J A; Strobbe, L J A; Boersma, L J; Linn, S C; Lobbes, M B I; Poortmans, P M P; Tjan-Heijnen, V C G; Van de Vijver, K K B T; de Vries, J; Westenberg, A H; Kessels, A G H; Smidt, M L.
Afiliación
  • van Roozendaal LM; Division of Surgical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. lorivanroozendaal@gmail.com.
  • de Wilt JH; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. lorivanroozendaal@gmail.com.
  • van Dalen T; Department of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800 6202 AZ, Maastricht, The Netherlands. lorivanroozendaal@gmail.com.
  • van der Hage JA; Division of Surgical Oncology, Radboud university medical centre, Nijmegen, The Netherlands. Hans.deWilt@radboudumc.nl.
  • Strobbe LJ; Division of Surgical Oncology, Diakonessenhuis Hospital, Utrecht, The Netherlands. TvDalen@diakhuis.nl.
  • Boersma LJ; Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. j.vd.hage@nki.nl.
  • Linn SC; Division of Surgical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands. ljastrobbe@cwz.nl.
  • Lobbes MB; Department of Radiation Oncology, Maastricht University Medical Centre (MAASTRO clinic), Maastricht, The Netherlands. liesbeth.boersma@maastro.nl.
  • Poortmans PM; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. liesbeth.boersma@maastro.nl.
  • Tjan-Heijnen VC; Division of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. s.linn@nki.nl.
  • Van de Vijver KK; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands. marc.lobbes@mumc.nl.
  • de Vries J; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. marc.lobbes@mumc.nl.
  • Westenberg AH; Department of Radiation Oncology, Radboud university medical centre, Nijmegen, The Netherlands. philip.poortmans@radboudumc.nl.
  • Kessels AG; Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.
  • Smidt ML; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.
BMC Cancer ; 15: 610, 2015 Sep 03.
Article en En | MEDLINE | ID: mdl-26335105
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ganglios Linfáticos / Mastectomía Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ganglios Linfáticos / Mastectomía Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido